Cormorant Asset Management, LP Biomea Fusion, Inc. Transaction History
Cormorant Asset Management, LP
- $1.43 Billion
- Q3 2024
A detailed history of Cormorant Asset Management, LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 3,570,872 shares of BMEA stock, worth $26 Million. This represents 2.53% of its overall portfolio holdings.
Number of Shares
3,570,872
Previous 3,570,872
-0.0%
Holding current value
$26 Million
Previous $16.1 Million
124.45%
% of portfolio
2.53%
Previous 1.24%
Shares
2 transactions
Others Institutions Holding BMEA
# of Institutions
104Shares Held
17.8MCall Options Held
1.68MPut Options Held
410K-
Black Rock Inc. New York, NY2.34MShares$17 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$15.3 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$10.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.38MShares$10 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA900KShares$6.54 Million0.02% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $213M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...